Evaluating the impact of discharging premature newborns weighing less than 2 kilos
Official title: Assessment of the Impact of the Return Home of Premature Newborns With Intrauterine Growth Retardation Weighing Less Than 2 Kilos (Low Birth Weight) on Short- and Long-term Morbidity/Mortality
Run by Hôpital NOVO · NCT06224764 · Data updated 2026-11-12
This study looks at how discharging premature newborns who weigh less than 2 kilos affects their health and survival, by gathering feedback from parents about their experiences.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Month to 11 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Hôpital NOVO Academic / other |
| Locations | 1 site (Pontoise) |
| Status | Recruiting |
| Started | February 21, 2024 |
| Main results expected | November 2025 |
| Study ends | November 2025 |
| Registry record updated | January 3, 2025 |
| Trial ID | NCT06224764 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are premature newborns born at less than 37 weeks of gestation who weigh less than 2 kg at discharge.
✕Probably not a fit
Patients who are transferred to another hospital before discharge or whose parents do not speak or understand French may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the short-term and long-term outcomes of premature newborns who weigh less than 2 kilos at the time of discharge from the neonatology department at Hôpital NOVO. It will involve collecting data through questionnaires from parents to understand the effects of early discharge on morbidity and mortality rates. The research focuses on the implications of current discharge criteria and the role of parental involvement and health worker support in the care of these vulnerable infants. The study will analyze data from newborns discharged between 2012 and 2024 to provide insights into the effectiveness of these practices.
Why it matters
Potential benefit: If successful, this study could lead to improved discharge protocols for premature infants, potentially reducing morbidity and mortality rates.
How similar studies have gone: Other studies have shown success in evaluating discharge criteria for premature infants, indicating that this approach is supported by existing research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Premature newborn baby (born at less than 37 days' gestation) * Newborn baby with IUGR (Intra-Uterine Growth Retardation) * Newborn baby hospitalised in the neonatology department of the NOVO hospital - Pontoise site * Patient born between 01/01/2012 and 31/12/2024. * Newborn who has left the neonatology department or the Kangaroo Unit to return home weighing less than 2 kg. * Newborn beneficiary of a social security scheme or entitled person. Exclusion Criteria: * Newborn transferred to another hospital before discharge. * Refusal by one of the parents. * Parent does not speak or understand French.
Where it's running
-
Resuscitation and neonatal medicine department - Hôpital NOVO - Pontoise site
Pontoise, France Recruiting
Study contacts
- Principal investigator: Dr Suzanne BORRHOMEE — Hôpital NOVO
- Study coordinator: Maryline DELATTRE
- Email: maryline.delattre@ght-novo.fr
- Phone: +3333130754131
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Wireless MicroPremVitals Button Sensor for the NICU
This study tests a tiny wireless sensor system to monitor heart rate, oxygen, and temperature in extremely preterm babies in the NICU to see if it works safely without wires.
-
Caffeine in pregnancy: how the mother and baby handle it during delivery
This study tests how caffeine is processed in pregnant people and how much reaches the baby when given shortly before delivery.
-
Neonatal data and biobank to understand what influences development in very preterm infants
This project will collect clinical information and biological samples to see if early biological, clinical, and environmental factors predict short- and long-term development in infants born before 32 weeks or under 1500 g.
-
Biomarkers in infants with prior neonatal brain injury
This project will test brain activity and development using games, EEG, and parent questionnaires in infants aged 3–24 months with and without prior neonatal brain injury.
-
PIOMI plus time‑based feeding to help preterm babies start oral feeds and gain weight
We will test whether a specific oral‑motor routine (PIOMI) and a time‑based (chronobiological) feeding approach help preterm infants born at 29–33 weeks begin oral feeding sooner and gain weight better.
-
Home air purifier to support lung recovery in babies born prematurely
This tests whether using an air purifier at home improves breathing and oxygen levels in babies who were born prematurely.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.